Anheuser-Busch InBev SA/NV
NYSE:BUDBeverages - Alcoholic
+$0.00 today
- Market cap
- $165.46B
- Beta
- 0.79
- P/E (TTM)
- 22.0
- EPS (TTM)
- $3.67
- Dividend yield
- 1.21%
Volume 1.61M
Average 1.96M
BUD Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Anheuser-Busch InBev SA/NVNYSE: BUD
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How BUD compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for BUD, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | $0 USD | — | — | 0.0% | |
| FY2025 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | R$0 BRL | — | — | 0.0% | |
| LTM Aug 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding BUD) | — | — | — | 0.0% | |
Competitors are the stored peer set for BUD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 54.3B | 57.79B | 59.38B | 59.77B | 59.32B |
| Cost of Revenue | 23.1B | 26.31B | 27.4B | 26.74B | 26.14B |
| Gross Profit | 31.21B | 31.48B | 31.98B | 33.02B | 33.18B |
| Gross Margin | 57.5% | 54.5% | 53.9% | 55.3% | 55.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 17.58B | 17.56B | 18.17B | 18.34B | 18.13B |
| Operating Expenses | 17.38B | 16.96B | 18.02B | 17.54B | 17.53B |
| Depreciation & Amortization | 5.05B | 5.08B | 5.41B | 5.54B | 5.65B |
| EBITDA | 17.79B | 18.98B | 19.07B | 20.3B | 20.84B |
| EBITDA Margin | 32.8% | 32.8% | 32.1% | 34.0% | 35.1% |
| Operating Income | 13.82B | 14.52B | 13.97B | 15.49B | 15.65B |
| Operating Margin | 25.5% | 25.1% | 23.5% | 25.9% | 26.4% |
| Interest Income | 112.82M | 294.16M | 565.88M | 589.96M | 628M |
| Interest Expense | 4.4B | 4.61B | 4.76B | 4.47B | 3.86B |
| Other Income / Expenses | (5.36B) | (4.99B) | (4.84B) | (4.92B) | (4.32B) |
| Income Before Tax | 8.46B | 9.52B | 9.12B | 10.57B | 11.33B |
| Pre-Tax Margin | 15.6% | 16.5% | 15.4% | 17.7% | 19.1% |
| Income Tax Expense | 2.35B | 1.93B | 2.23B | 3.15B | 2.85B |
| Net Income | 4.67B | 5.97B | 5.34B | 5.86B | 6.84B |
| Net Margin | 8.6% | 10.3% | 9.0% | 9.8% | 11.5% |
| EPS (Basic) | 2.33 | 2.97 | 2.65 | 2.92 | 3.46 |
| EPS (Diluted) | 2.28 | 2.91 | 2.60 | 2.86 | 3.46 |
| Weighted Avg Shares | 2.01B | 2.01B | 2.02B | 2B | 1.98B |
| Weighted Avg Shares (Diluted) | 2.05B | 2.05B | 2.05B | 2.04B | 1.98B |
Anheuser-Busch InBev SA/NV
NYSE:BUD
Intrinsic Alpha fair value
Locked
Current Price
$82.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.